Properties
Description
MG-132 interferes with the proteasome’s ability to degrade proteins, thereby disrupting cellular processes in cancer cells, particularly multiple myeloma. It targets Proteasome.
Molecular Formula
C26H41N3O5
Targets
Proteasome: 100 nM
Identity
Confirmed by NMR/HPLC/MS.
Applications
MG-132 is utilized to inhibit proteasome activity, playing an important role in studies concerning protein degradation and cancer treatment strategies.